Title : The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension.

Pub. Date : 2006

PMID : 17083267






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The ASCOT-BPLA trial underlines the cardiovascular benefit of ACE inhibitors, specifically perindopril, beyond that provided by BP reduction, and potentially reflects a mechanistic feature of the ACE inhibitors. Benzo(a)pyrene angiotensin I converting enzyme Homo sapiens
2 The ASCOT-BPLA trial underlines the cardiovascular benefit of ACE inhibitors, specifically perindopril, beyond that provided by BP reduction, and potentially reflects a mechanistic feature of the ACE inhibitors. Benzo(a)pyrene angiotensin I converting enzyme Homo sapiens